Respiratory Disease Clinical Trial
Official title:
Contribution of Four Pulmonary Function Tests to Diagnosis in Patients With Respiratory Symptoms in the Primary Care.
Contribution of four pulmonary function tests to diagnosis in patients with respiratory symptoms in the primary care.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | September 25, 2018 |
Est. primary completion date | July 25, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - all subjects: 18 or older than 18 years old and younger than 80 years old - send by a general practitioner for a lung function test Exclusion Criteria: - subjects, younger than 18 years old - not able to perform the lung function tests - incomplete lung function tests - disease already diagnosed - already follow up by a pulmonologist - preoperative test |
Country | Name | City | State |
---|---|---|---|
Belgium | CHU St Pierre | Brussels |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire Saint Pierre |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | number of cases in which the four lung function tests are contributing to the final diagnosis | number of cases in which the four lung function tests are contributing to the final established diagnosis compared to spirometry alone | at study completion | |
Secondary | number of cases in which additional tests were performed | number of cases in which additional tests were needed to establish the correct final diagnosis, after the performance of the four lung function tests | at study completion | |
Secondary | changes in treatment after the four lung function tests | changes in treatment, prescribed by the primary physician, after the performance of the four lung function tests | at study completion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03376204 -
Pain Mechanisms in Patients With Bronchiectasis
|
||
Not yet recruiting |
NCT05902702 -
Isotonic Saline for Children With Bronchiolitis
|
N/A | |
Recruiting |
NCT05246098 -
REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI
|
||
Completed |
NCT04467190 -
Investigation of Inflammacheck to Measure Exhaled Breath Condensate Hydrogen Peroxide in Respiratory Conditions
|
||
Not yet recruiting |
NCT05374148 -
Respiratory Health Problems Among Workers in Ferrosilicon Alloys Industry in Aswan-Eygpt.
|
||
Recruiting |
NCT04502368 -
Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients
|
||
Recruiting |
NCT05775952 -
Airway Remodeling and Rhinovirus in Asthmatics
|
||
Active, not recruiting |
NCT02681848 -
What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?
|
||
Recruiting |
NCT06002685 -
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
|
N/A | |
Enrolling by invitation |
NCT03319446 -
Collection of Anonymized Samples
|
N/A | |
Recruiting |
NCT04287959 -
SWISH Trial (Strategies for Weaning Infants on Supportive High Flow)
|
N/A | |
Completed |
NCT05017727 -
Closed-loop Oxygen Control in Ventilated Infants Born at or Near Term
|
||
Completed |
NCT04607330 -
Protein Top-up Acceptability Study for Patients With Increased Protein Needs
|
N/A | |
Completed |
NCT03334916 -
A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients
|
Phase 4 | |
Completed |
NCT04649736 -
Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients
|
N/A | |
Completed |
NCT03661801 -
Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
|
||
Enrolling by invitation |
NCT03322254 -
How Respiratory Pathogens Panel Results Affect Patients' Plan of Care
|
||
Recruiting |
NCT03937583 -
Screening for Cancer in Patients With Unprovoked VTE
|
Phase 4 | |
Not yet recruiting |
NCT06026163 -
Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress
|
Phase 2/Phase 3 | |
Completed |
NCT04581096 -
Mapping COVID-19 Spread in a Tertiary Hospital
|